and is therefore different from other imaging methods that only assess abnormalities of structure. The primary MRSI technique that is currently available commercially utilizes the point-resolved spectroscopy sequence [5] , with spectral spatial pulses for lipid suppression [6] [7] [8] . In particular, endorectal MRI and MRSI have shown considerable promise in the evaluation of tumor extent and aggressiveness in patients with biopsy-proven prostate cancer [9] [10] [11] and might be valuable in tumor diagnosis.
Cancer tissue can appear in any place in the prostate, and so the use of a three-dimensional (3D) MRSI method to cover the whole prostate is necessary [12] . MRI may improve the staging of prostate cancer compared with clinical evaluation alone, computer tomography, or transrectal ultrasound, as it allows simultaneous and detailed assessment of prostatic, periprostatic, and pelvic anatomy. Earlier reports suggesting a limited applicability of MRI did not incorporate MRSI or the use of endorectal coils, and they used sequences and equipment that were not up to current standards. The value of MRSI to detect and localize cancer in the transition zone of the prostate has been reported [13, 14] . Prostate cancer has been shown to be characterized by a decreased signal of citrate (Cit) and an increased signal of choline (Cho)-containing compounds. Therefore, a commonly used marker for cancer tissue is the ratio of [Cho + creatine (Cr)]/Cit. The purpose of the study was to record 3D MRSI and to compare metabolite ratios using spectroscopic imaging data between 2 different Gleason scores (3 + 3 = 6 vs. 4 + 3 = 7).
Materials and Methods
The entire protocol was approved by the Institutional Review Board, and informed consent was obtained from each patient. Patient selection was limited to GS 6 or 7 and prostatectomy. Fourteen men [n = 7 with a GS (3 + 3) and n = 7 with a GS (4 + 3)] underwent radical retropubic prostatectomy, and their pathologies were subsequently analyzed. These patients were scanned using a 1.5-tesla Siemens (Siemens Medical Solution, Erlangen, Germany) MRI scanner with an endorectal coil. The protocol combining MRI and MRS was performed at least 8 weeks after transrectal ultrasound-guided sextant biopsy. MRI included T 2 -weighted images acquired with a fast spin-echo sequence with: repetition time (TR) = 3,800 ms, effective echo time (TE) = 101 ms, slice thickness = 3 mm, field of view = 140 mm, and matrix size = 256 ! 256. The ages of the patients ranged from 52 to 78 years, and the patients had 2 different GS: 3 + 3 (mean 8 SD, 56.8 8 7.9 years) and 4 + 3 (mean 8 SD, 64.8 8 8.6 years). The mean and standard deviation of prostate-specific antigen value for the patients with a GS of 3 + 3 was 7.2 8 2.5 ng/ml. For patients with a GS of 4 + 3, it was 13.5 8 3.1 ng/ml. MRSI was performed in all patients, including water-and fatsuppressed acquisition. The parameters were: TR/TE/Avg/BW = 700 ms/120 ms/6 ms/1,300 Hz, and 512 spectral data points, where TR, TE, Avg, and BW represent repetition time, echo time, averages and spectral bandwidth. The field of view was 80 ! 80 ! 80 mm 3 with a raw matrix size of 512 ! 12 ! 12 ! 12. A point-resolved spectroscopy pulse sequence was used to acquire the proton MR spectra from a volume of interest of 55 ! 40 ! 40 mm 3 . Outer volume lipid suppression was achieved using eight 3-cm slab saturation pulses around the volume of interest. Water and fat resonances were suppressed using two 12.6-ms dual-frequency selective MEGA pulses [15] with crusher gradients. A TE of 120 ms was used for optimal Cit detection.
The spectroscopy software on the MR scanner provided by the manufacturer was used to evaluate the (Cho + Cr)/Cit ratio. For 3D MRSI postprocessing, each spectrum was Fourier transformed, frequency-, phase-, and baseline-corrected, and peaks of Cit, Cho and Cr were subsequently fitted. Hamming filter was used for the MRSI spatial dimensions of the data. For the statistical analysis, the Student t test was used to compare the ratios between different GS, and a p value of less than 0.05 was considered to indicate a significant difference. A radiologist (D.M.) and a physicist (M.A.T.), both with more than 10 years of experience in analyzing prostate endorectal MRI and MRSI data, interpreted the imaging studies using established morphologic and metabolic criteria for the MRI and MRSI evaluation of prostate cancer. The spectroscopist evaluated the MRSI data set and provided the location and number of suspicious voxels to the radiologist, who integrated the MRSI information with the MRI data and provided a final reading for each study. In the decision status for classifying voxels as noncancerous or malignant, the voxels were first broken up according to their GS and noncancerous regions. If the Cit peak was lower than the Cho peak or was undetectable, the voxel was determined to be malignant. If the Cit peak was higher than the Cho peak, the voxel was considered noncancerous for (Cho + Cr)/Cit smaller than 0.37 and malignant for (Cho + Cr)/Cit greater than 0.37.
Statistical Test
The mean and standard deviation of (Cho + Cr)/Cit were calculated. Statistical analysis was conducted using the Student t test between 2 different GS. A value of p ! 0.05 was considered to be significant.
Results
The one-dimensional (1D) spectra extracted from the 3D MRSI data recorded in the affected and contralateral area of a 67-year-old prostate cancer patient with a GS of 6 (3 + 3) are shown in figure 1 a and table 1 . There were no statistically significant changes observed in the (Cho + Cr)/ Cit ratios with GS. However, a trend was visible, i.e. GS 7 had a higher (Cho + Cr)/Cit ratio compared to GS 6.
Discussion
Endorectal MRI and MRSI facilitate improved diagnosis of prostate cancer in patients with 2 different GS. The ratio of (Cho + Cr)/Cit is capable of distinguishing between healthy and cancerous prostate tissues. MR spectroscopy of the prostate is a noninvasive approach for the detection of prostate cancer, and the potential of MR spectroscopy to identify intraprostatic cancer foci in addition to MRI with a high sensitivity and specificity has already been proven in several studies [16, 17] . So far, the emphasis in MRSI of the prostate was placed on the peripheral zone [18] resulting from the fact that the signalto-noise ratio in the peripheral zone is superior to the central gland because the endorectal coil is positioned against the dorsal part of the prostate which contains the peripheral zone. Seventy percent of tumor nodules are present in the peripheral zone [19, 20] . As the GS increased, the metabolite ratio of (Cho + Cr)/Cit also elevated. Numerous investigators have also found elevated Cho levels in tumors [21] [22] [23] . Since these compounds are anabolites (Cho and phosphocholine) and catabolites (glycerophosphocholine) of phosphatidylcholine, which is a major membrane phospholipid, it has been suggested that the elevated Cho level reflects an elevated cell proliferation rate, and there are some data to support this hypothesis [24] . Even though the metabolite ratio measured by MRSI did not show statistically significant changes, there are higher levels of Cho-containing metabolites in prostate cancers having higher Gleason grades, which agrees with a previous study [25] . There is an overlap between MRSI parameters at various GS levels, which may reflect methodological and physiological variations.
Conclusion
Our study showed that the metabolite ratio of (Cho + Cr)/Cit in MRSI measurement of prostate cancer increased with an increase of these 2 GS (GS 3 + 3 and GS 4 + 3). MRSI has potential in noninvasive evaluation of prostate cancer aggressiveness. 
